News

Schott has begun mass production of its Schott TopLyo pharmaceutical packaging for lyophilized (freeze-dried) drugs at its Muellheim, Germany facility. The Schott TopLyo packaging solution features a special

Wedgewood Pharmacy is compounding oseltamivir phosphate in a cherry-flavored suspension in response to the nationwide shortage of Tamiflu suspension. The commercially manufactured Tamiflu product, from F Hoffmann-La Roche,

NeurogesX has received approval from FDA for Qutenza (capsaicin) 8% patch, the first and only product containing prescription strength capsaicin, for the management of neuropathic pain due to

Artes Biotechnology and Rhein Minapharm Biogenetics, a subsidiary of Minapharm have reported the successful production of a new target of a therapeutic protein. This is the first result

NovaDel Pharma (NovaDel) has enter into an exclusive license and distribution agreement with ECR Pharmaceuticals, a wholly owned subsidiary of Hi-Tech Pharmacal to commercialise and manufacture ZolpiMist in the

Sanofi Pasteur has reported that the French drug agency has granted marketing authorisation in France for Panenza, its non-adjuvanted Influenza A(H1N1) 2009 monovalent vaccine. The vaccine was made

GlaxoSmithKline (GSK) and Nabi Biopharmaceuticals (Nabi) have reported a licensing agreement for a nicotine conjugate candidate vaccine (NicVAX), and for the development of a second generation nicotine vaccine.

MeadWestvaco (MWV) has released the results of a study that the company commissioned on packaging damage. Results revealed that damaged packaging has a profound effect on shoppers’ purchasing

India-based Glenmark has entered into an exclusive license agreement with Medicis Pharmaceutical to co-develop and commercialise a specialty pharmaceutical product in North America. The product will be used